SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 12/04/2017
Entire Document
 
Medtronic plc
Notes to Consolidated Financial Statements
(Unaudited)


The following table summarizes the Company's investments by significant investment category and the related consolidated balance sheet classification at October 27, 2017:
 
Valuation
 
Balance Sheet Classification
(in millions)
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair Value
 
Investments
 
Other Assets
Available-for-sale securities:
 

 
 

 
 

 
 

 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agency securities
$
613

 
$
1

 
$
(8
)
 
$
606

 
$
606

 
$

Marketable equity securities
84

 
115

 
(1
)
 
198

 

 
198

Total Level 1
697

 
116

 
(9
)
 
804

 
606

 
198

Level 2:
 
 
 
 
 
 
 
 
 
 
 
Corporate debt securities
4,165

 
64

 
(16
)
 
4,213

 
4,213

 

U.S. government and agency securities
870

 

 
(12
)
 
858

 
858

 

Mortgage-backed securities
768

 
7

 
(19
)
 
756

 
756

 

Foreign government and agency securities
52

 

 

 
52

 
52

 

Other asset-backed securities
341

 
1

 
(1
)
 
341

 
341

 

Debt funds
939

 
6

 
(168
)
 
777

 
777

 

Total Level 2
7,135

 
78

 
(216
)
 
6,997

 
6,997

 

Level 3:
 
 
 
 
 
 
 
 
 
 
 
Corporate debt securities
1

 

 

 
1

 

 
1

Auction rate securities
47

 

 
(3
)
 
44

 

 
44

Total Level 3
48

 

 
(3
)
 
45

 

 
45

Investments measured at net asset value(1):
 

 
 

 
 

 
 

 
 
 
 
Debt Funds
400

 

 
(6
)
 
394

 
394

 

Total available-for-sale securities
8,280

 
194

 
(234
)
 
8,240

 
7,997

 
243

Cost method, equity method, and other investments:
 
 
 
 
 
 
 
 
 
 
 
Level 3:
 
 
 
 
 
 
 
 
 
 
 
Cost method, equity method, and other investments
626

 

 

 
N/A

 

 
626

Total Level 3
626

 

 

 
N/A

 

 
626

Total cost method, equity method, and other investments
626

 

 

 
N/A

 

 
626

Total investments
$
8,906

 
$
194

 
$
(234
)
 
$
8,240

 
$
7,997

 
$
869

(1) Certain investments that are measured at the net asset value per share (or its equivalent) as a practical expedient are excluded from the fair value hierarchy. The fair value amounts presented herein are intended to permit reconciliation to the consolidated balance sheets.


11

X